Medicare Enrolled

Dr. Steven Eng, M.D.

Endocrinology · Long Beach, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3300 E. SOUTH STREET, Long Beach, CA 90805
5626349803
In practice since 2006 (19 years)
NPI: 1881798189 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Eng from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eng? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Eng

Dr. Steven Eng is an endocrinology specialist in Long Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Eng performed 2,172 Medicare services across 934 unique beneficiaries.

Between the years covered by Open Payments, Dr. Eng received a total of $10,320 from 52 pharmaceutical and/or device companies across 598 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Eng is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 28% volume in CA $10,320 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,172
Medicare services
Top 28% in CA for endocrinology
934
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~114 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,195 $100 $150
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
633 $67 $130
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
181 $28 $60
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
105 $111 $350
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
58 $143 $320
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,320
Total received (2018-2024)
Avg $1,474/year across 7 years
Top 19% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
598
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,296 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,390
2023
$1,692
2022
$1,198
2021
$1,091
2020
$1,354
2019
$1,779
2018
$1,815

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$424
Dexcom, Inc.
$249
Abbott Laboratories
$166
Novo Nordisk Inc
$103
Tandem Diabetes Care, Inc.
$63
Mannkind Corporation
$60
Verity Pharmaceuticals Inc.
$39
ABBVIE INC.
$33
RECORDATI_RARE_DISEASES_INC.
$33
Acera Surgical, Inc.
$32
Radius Health, Inc.
$31
Corcept Therapeutics
$27
Bayer Healthcare Pharmaceuticals Inc.
$27
Ascensia Diabetes Care Us Inc.
$23
Amgen Inc.
$20
Acella Pharmaceuticals, LLC
$18
Alvogen Inc
$15
Medtronic, Inc.
$14
CeQur Corporation
$14
Top 3 companies account for 60.4% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$2,058
Novo Nordisk Inc
$1,161
Mannkind Corporation
$669
Dexcom, Inc.
$641
Paragon 28, Inc.
$556
Abbott Laboratories
$513
MannKind Corporation
$511
SANOFI-AVENTIS U.S. LLC
$433
Stryker Corporation
$415
Amarin Pharma Inc.
$268
AstraZeneca Pharmaceuticals LP
$254
Embecta Corp.
$242
Insulet Corporation
$242
LifeScan, Inc.
$168
Boehringer Ingelheim Pharmaceuticals, Inc.
$164
Corcept Therapeutics
$150
Amgen Inc.
$134
Radius Health, Inc.
$130
Becton, Dickinson and Company
$96
Horizon Therapeutics plc
$96
Tandem Diabetes Care, Inc.
$92
Medtronic MiniMed, Inc.
$88
ABBVIE INC.
$86
CeQur Corporation
$75
Ascensia Diabetes Care Us Inc.
$70
Alvogen Inc
$70
Medtronic, Inc.
$66
Merck Sharp & Dohme Corporation
$59
RECORDATI_RARE_DISEASES_INC.
$57
Janssen Pharmaceuticals, Inc
$57
Bayer Healthcare Pharmaceuticals Inc.
$53
LIFESCAN, INC.
$48
Integra LifeSciences Corporation
$48
Xeris Pharmaceuticals, Inc.
$47
Bayer HealthCare Pharmaceuticals Inc.
$46
Zealand Pharma US, Inc.
$46
Antares Pharma, Inc.
$45
Verity Pharmaceuticals Inc.
$39
Acella Pharmaceuticals, LLC
$36
Acera Surgical, Inc.
$32
Ascensia Diabetes Care US Inc.
$30
Aroa Biosurgery Incorporated
$26
AbbVie Inc.
$25
Alexion Pharmaceuticals, Inc.
$24
Esperion Therapeutics, Inc.
$23
Bone Support Inc.
$23
Bigfoot Biomedical Inc
$22
Shire North American Group Inc
$21
IBSA Pharma Inc.
$19
Amryt Pharma Holdings Ltd
$19
PFIZER INC.
$17
Kowa Pharmaceuticals America, Inc.
$13
Top 3 companies account for 37.7% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ALLOGRAFT · ALLOWRAP · ANCHORAGE · APIDRA · AUGMENT INJECTABLE · AXSOS · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BILAYER WOUND MATRIX BWM · CERAMENTBONE VOID FILLER · CeQur Simplicity · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · EX-FIX · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LYUMJEV · Levemir · Livalo · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 530G · Minimed 670G System · NATPARA · NEUROFLEX · NEXLETOL · NP Thyroid 60 · OMNIGRAFT · ONETOUCH VERIO REFLECT · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · OneTouch · OneTouch Verio Reflect · Otrexup · Ozempic · PEEK INTRALINE · PRODUCT PORTFOLIO · RAYOS · RYBELSUS · Repatha · Restrata Wound Matrix · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SONICANCHOR · SYNTHROID · Saxenda · Strensiq · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tlando · Tresiba · Tymlos · UNITY DIABETES MANAGEMENT SYSTEM · Vascepa · Victoza · XYOSTED · ZEGALOGUE · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Long Beach?
Compare endocrinologists in the Long Beach area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
298
Per 100K population
3.0
County median income
$87,760
Nearest hospital
UCI HEALTH-LAKEWOOD
2.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Eng is a clinical cardiology specialist, with above-average Medicare volume (top 28% in CA), with low-engagement industry engagement in the top 19% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Eng experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Eng performed 1,195 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eng receive payments from pharmaceutical companies?
Yes. Dr. Eng received a total of $10,320 from 52 companies across 598 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eng's costs compare to other endocrinologists in Long Beach?
Dr. Eng's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eng) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →